Birgitta Grundmark

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.

Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.

Journal: Drug safety

Published: June 24, 2021

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.

Journal: Drug safety

Published: September 08, 2020

A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.

A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.

Journal: Drug safety

Published: July 19, 2020

Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.

Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.

Journal: Drug safety

Published: February 03, 2020

Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects.

Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects.

Journal: Upsala journal of medical sciences

Published: August 08, 2018

Letter to the Editor Regarding "Natalizumab-Associated Primary Central Nervous System Lymphoma".

Letter to the Editor Regarding "Natalizumab-Associated Primary Central Nervous System Lymphoma".

Journal: World neurosurgery

Published: January 19, 2018

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.

Journal: Drug safety

Published: September 22, 2017

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.

Journal: International journal of cancer

Published: June 07, 2016

A latent class model for competing risks.

A latent class model for competing risks.

Journal: Statistics in medicine

Published: November 18, 2015

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Journal: Drug safety

Published: January 29, 2015

Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish men.

Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish men.

Journal: Nutrition and cancer

Published: December 12, 2013

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area.

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area.

Journal: European journal of clinical pharmacology

Published: August 21, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026